Eighty-two healthy , HIV uninfected , South African adults , with a BCG scar and tuberculin skin test ( TST ) diameter 15 mm , were randomized to receive 6 months of INH , starting either before , or 6 months after , intradermal revaccination with BCG Vaccine SSI ( Statens Serum Institut , Copenhagen ) .